Chemistry:Tolebrutinib
From HandWiki
Tolebrutinib is an investigational new drug that is being evaluated to treat multiple sclerosis.[1] It is a Bruton's tyrosine kinase (BTK) inhibitor.[2]
References
- ↑ "Tolebrutinib - Sanofi". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800050681.
- ↑ "Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis". Drugs in R&D 24 (2): 263–274. June 2024. doi:10.1007/s40268-024-00468-4. PMID 38965189.
 |  |
